British-Swedish firm Astrazeneca said it had resumed testing of the coronavirus vaccine from the University of Oxford in the UK following confirmation from the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a …
Read More »Covaxin Coronavirus Vaccine Animal Trials Succeeded, Announces Bharat Biotech
A photo shows an employee showing a vial with the “Gam-COVID-Vac” vaccine against the coronavirus disease, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology in Russia on August 7, 2020. (Reuters ) Bharat Biotech said the results demonstrated the protective efficacy of the Covid-19 vaccine in a …
Read More »Explained: Why Oxford Vaccine Trials Have Been Stopped In India And Why This May Not Be A Serious Hit
Written by Prabha Raghavan, edited by Explained Desk | New Delhi | Updated: September 11, 2020 6:23:32 pm An employee is treated at the Special Immunobiological Reference Center (CRIE) of the Federal University of Sao Paulo (Unifesp) where the Oxford / AstraZeneca coronavirus vaccine trials were being carried out, in …
Read More »Brazil and Turkey plan to conduct phase III trials of Russia’s Sputnik V: the latest in coronavirus vaccine
The race to find a coronavirus vaccine continues, but it has been a mixed week in that search so far. AstraZeneca had to pause its vaccine trials when a woman developed severe neurological symptoms, the drugmaker told news agencies on Thursday. The Comptroller General of Drugs of India asked the …
Read More »Coronavirus Vaccine Update: From Oxford Trial Pause to Sinovac’s Good Results, Here Are All Updates on COVID Vaccine Development
Covaxin, India’s first homegrown attempt to fight the pandemic, has undergone rapid testing and is now in the midst of medium-scale testing. According to experts, if all goes well, the deadline for vaccine delivery could be sped up even further and India could see millions of doses ready by early …
Read More »One Day After Regulator Notification, Serum Says Oxford Vaccine Trials Paused In India
Written by Prabha Raghavan | New Delhi | Updated: September 11, 2020 7:29:25 am Covid-19 testing in New Delhi. IBS Sponsors Mid- and Late-Stage Human Clinical Trials for Candidate Vaccine in India Serum Institute of India has decided to stop the ongoing clinical trials in India of the Covid-19 candidate …
Read More »Russia begins administering covid vaccine to volunteers
Russia has begun to inoculate volunteers in Moscow as part of the phase 3 trial of the country’s coronavirus vaccine, the AFP news agency reported, citing the capital’s deputy mayor. “The first participants have already been vaccinated in clinics in the capital,” Deputy Mayor Anastasia Rakova, head of social development, …
Read More »Serum Institute Stops Covid-19 Vaccine Trials In India Even As AstraZeneca Says End-of-Year Launch Still Possible
In this illustration, taken on April 10, 2020, small vials labeled with a “COVID-19 Vaccine” label and a medical syringe are seen (REUTERS / Dado Ruvic / Illustration / File photo). The Serum Institute of India halted trials of the Covid-19 vaccine in India one day after AstraZeneca halted trials …
Read More »Oxford Vaccine: Serum Institute Suspends AstraZeneca Covid-19 Vaccine Trials in India | India News
MUMBAI / LONDON: The Serum Institute of India has suspended trials of AstraZeneca’s Covid-19 vaccine candidate until the British drugmaker restarts trials, Serum said on Thursday. “We are reviewing the situation and stopping the trials in India,” Serum said in a short statement. AstraZeneca said Tuesday that it had halted …
Read More »Live updates of the day 169 of the closure of the coronavirus in India | Red Line, Violet Line, Green Line resume services in New Delhi after 172 days
One day after AstraZeneca suspended its COVID-19 tests, Serum Institute of India is under fire for failing to pause its clinical trial in India. IBS is conducting phase 3 trials in people in India involving UK-based AstraZeneca’s COVID-19 vaccine candidate. However, Pune-based SII has said there have been no “problems” …
Read More »